Are Catgut Suture Manufacturers in India Still Relevant? Comparing Traditional Catgut with Synthetic Absorbable Sutures

 In surgery, materials rarely disappear. They fade, narrow, and settle into smaller roles. Catgut sutures in India are doing exactly that. Once central to absorbable wound closure, they now occupy a more specific, less visible space. Meanwhile, synthetic alternatives have moved from “advanced option” to everyday expectation. The question, then, is not whether catgut is outdated, but whether its manufacturers still fit the shape of modern surgical demand.

That distinction matters.

How Routine Turned Into Legacy

Catgut sutures became standard long before surgeons spoke the language of polymers or tensile curves. Their appeal was direct. They absorbed naturally, removed the need for follow-up, and could be produced at scale. In a healthcare system under constant pressure, that combination worked.

In India, adoption was not driven by marketing or innovation cycles. It was driven by repetition. Surgeons trained with catgut continued using it. Hospitals stocked what procurement systems understood. Manufacturers responded to steady demand rather than shifting preference.

Over time, catgut stopped being a choice and became background infrastructure.

The Cost of Biological Variability

What once passed as acceptable variability now reads as uncertainty. Catgut’s absorption depends on enzymatic activity, which differs across tissue types and patient conditions. Inflammation is not unusual. Tensile strength declines in ways that are difficult to time precisely.

For routine closures, this may still be manageable. For surgeries that demand control—internal suturing, layered closure, cosmetic outcomes, it becomes a liability. Not a failure, but a limitation.

Modern surgery increasingly treats variability as risk, even when outcomes are usually adequate.

Why Synthetic Sutures Didn’t Need a Hard Sell

Synthetic absorbable sutures did not displace catgut by dramatic superiority. They did so by removing guesswork. Hydrolytic degradation behaves the same way regardless of immune response or tissue environment. Strength retention follows a schedule. Absorption does not surprise the surgeon.

A synthetic Absorbable Suture is predictable in a way biological materials cannot be. That predictability aligns neatly with contemporary surgical training, minimally invasive techniques, and standardized protocols.

As expectations tightened, synthetics simply fit better.

Relevance Depends on Where You Look

It would be easy to declare catgut obsolete by focusing only on tertiary hospitals and premium surgical centers. That view ignores how fragmented Indian healthcare actually is.

Large sections of the system still prioritize cost control, availability, and familiarity. In these environments, catgut remains useful. It is stocked because it is known. It is used because outcomes are acceptable within the constraints of the setting.

This is not inertia alone. It is adaptation to circumstance.

But relevance built solely on constraint is fragile.

Manufacturing at a Crossroads

Catgut manufacturers in India are not irrelevant. They are exposed. Their future depends on whether they treat current demand as a ceiling or a foundation.

Surgical buyers are no longer purchasing products in isolation. They are evaluating suppliers. Range matters. Compliance matters. Alignment with evolving clinical practice matters.

This is where companies such as Lotus Surgicals illustrate a more sustainable approach. Relevance today comes from breadth and responsiveness, not from defending a single material category.

Manufacturing strategy has become as important as manufacturing skill.

The Market’s Quiet Direction

Synthetic absorbable sutures will continue to gain share, not because catgut fails, but because surgery increasingly demands repeatable behavior. As pricing stabilizes and awareness spreads, the shift will deepen.

Catgut will likely persist, but within clearer boundaries. Specific procedures. Specific settings. Specific constraints.

This is not a disappearance. It is a contraction.

The manufacturers who remain relevant will be those who recognize that contraction early and adjust accordingly. The suture market is not nostalgic. It remembers what works, but it invests in what fits next.